The mortality rate is around 95% for untreated cases, but the prognosis is reasonably favorable (80–90% survival) for people with idiopathic<unk>  diagnosed and treated early with plasmapheresis.
Thrombotic thrombocytopenic purpura
Atypical hemolytic uremic syndrome
Drug-induced thrombocytopenic purpura
Hemolytic–uremic syndrome
Immune thrombocytopenic purpura
Disseminated intravascular coagulation
Heparin-induced thrombocytopenia
Gray platelet syndrome